217 related articles for article (PubMed ID: 26771878)
1. Lung Transplantation for Lymphangioleiomyomatosis in Japan.
Ando K; Okada Y; Akiba M; Kondo T; Kawamura T; Okumura M; Chen F; Date H; Shiraishi T; Iwasaki A; Yamasaki N; Nagayasu T; Chida M; Inoue Y; Hirai T; Seyama K; Mishima M;
PLoS One; 2016; 11(1):e0146749. PubMed ID: 26771878
[TBL] [Abstract][Full Text] [Related]
2. Mayo clinic experience of lung transplantation in pulmonary lymphangioleiomyomatosis.
Ussavarungsi K; Hu X; Scott JP; Erasmus DB; Mallea JM; Alvarez F; Lee AS; Keller CA; Ryu JH; Burger CD
Respir Med; 2015 Oct; 109(10):1354-9. PubMed ID: 26321137
[TBL] [Abstract][Full Text] [Related]
3. Single lung transplantation for lymphangioleiomyomatosis: a single-center experience in Japan.
Oishi H; Watanabe T; Matsuda Y; Noda M; Ejima Y; Saiki Y; Seyama K; Kondo T; Okada Y
Surg Today; 2018 Oct; 48(10):944-950. PubMed ID: 29808303
[TBL] [Abstract][Full Text] [Related]
4. Experience of Lung Transplantation in Patients with Lymphangioleiomyomatosis at a Brazilian Reference Centre.
Baldi BG; Samano MN; Campos SV; de Oliveira MR; Junior JEA; Carraro RM; Teixeira RHOB; Minguini IP; Burlina R; Pato EZS; Carvalho CRR; Costa AN
Lung; 2017 Dec; 195(6):699-705. PubMed ID: 28823029
[TBL] [Abstract][Full Text] [Related]
5. Favorable survival even with high disease-specific complication rates in lymphangioleiomyomatosis after lung transplantation-long-term follow-up of a Japanese center.
Kurosaki T; Otani S; Miyoshi K; Okazaki M; Sugimoto S; Suno M; Yamane M; Kobayashi M; Oto T; Toyooka S
Clin Respir J; 2020 Feb; 14(2):116-123. PubMed ID: 31729820
[TBL] [Abstract][Full Text] [Related]
6. The US experience with lung transplantation for pulmonary lymphangioleiomyomatosis.
Kpodonu J; Massad MG; Chaer RA; Caines A; Evans A; Snow NJ; Geha AS
J Heart Lung Transplant; 2005 Sep; 24(9):1247-53. PubMed ID: 16143241
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Effect of Sirolimus for Lymphangioleiomyomatosis Remaining in the Abdominopelvic Region After Lung Transplantation: A Case Report.
Ito T; Suno M; Sakamoto K; Yoshizaki Y; Yamamoto K; Nakanishi R; Hirano Y; Irie M; Kurosaki T; Otani S; Yamane M; Sugimoto S; Miyoshi K; Oto T
Transplant Proc; 2016; 48(1):271-4. PubMed ID: 26915883
[TBL] [Abstract][Full Text] [Related]
8. Should mammalian target of rapamycin inhibitors be stopped in women with lymphangioleiomyomatosis awaiting lung transplantation?
El-Chemaly S; Goldberg HJ; Glanville AR
Expert Rev Respir Med; 2014 Dec; 8(6):657-60. PubMed ID: 25199529
[TBL] [Abstract][Full Text] [Related]
9. Clinical features of 280 hospitalized patients with lymphangioleiomyomatosis in Japan.
Hasegawa W; Yamauchi Y; Yasunaga H; Sunohara M; Jo T; Matsui H; Fushimi K; Takami K; Nagase T
Respirology; 2015 Jan; 20(1):160-5. PubMed ID: 25385157
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Results of Bilateral Lung Transplantation in Patients With End-Stage Pulmonary Lymphangioleiomyomatosis.
Salman J; Ius F; Sommer W; Siemeni T; Fleissner F; Alhadidi H; Kugler C; Avsar M; Haverich A; Warnecke G; Tudorache I; Kuhn C
Prog Transplant; 2019 Jun; 29(2):115-121. PubMed ID: 31084354
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes and survival following lung transplantation in patients with lymphangioleiomyomatosis.
Khawar MU; Yazdani D; Zhu Z; Jandarov R; Dilling DF; Gupta N
J Heart Lung Transplant; 2019 Sep; 38(9):949-955. PubMed ID: 31303421
[TBL] [Abstract][Full Text] [Related]
12. Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complications.
Almoosa KF; Ryu JH; Mendez J; Huggins JT; Young LR; Sullivan EJ; Maurer J; McCormack FX; Sahn SA
Chest; 2006 May; 129(5):1274-81. PubMed ID: 16685019
[TBL] [Abstract][Full Text] [Related]
13. Reduced risk of recurrent pneumothorax for sirolimus therapy after surgical pleural covering of entire lung in lymphangioleiomyomatosis.
Sakurai T; Arai T; Hirose M; Kojima K; Sakamoto T; Matsuda Y; Sugimoto C; Yoon HE; Inoue Y
Orphanet J Rare Dis; 2021 Nov; 16(1):466. PubMed ID: 34732225
[TBL] [Abstract][Full Text] [Related]
14. A survey of use of mTOR inhibitors in patients with lymphangioleiomyomatosis listed for lung transplant.
Warrior K; Leard LE; Nair AR; Gries CJ; Fisher AJ; Johnson SR; McCormack FX; Dilling DF
Respir Med; 2022; 195():106779. PubMed ID: 35276437
[TBL] [Abstract][Full Text] [Related]
15. Sirolimus treatment for recurrent lymphangioleiomyomatosis after lung transplantation.
Chen F; Omasa M; Kondo N; Fujinaga T; Shoji T; Sakai H; Bando T
Ann Thorac Surg; 2009 Jan; 87(1):e6-7. PubMed ID: 19101258
[TBL] [Abstract][Full Text] [Related]
16. [Perioperative management of lung transplantations in patients with pulmonary arterial hypertension compared with that in patients with lymphangiomyomatosis].
Adachi K; Kurosawa S; Wagatsuma T; Yamamoto Y; Kameyama E; Nishino R
Masui; 2013 May; 62(5):573-9. PubMed ID: 23772531
[TBL] [Abstract][Full Text] [Related]
17. Relapse of Lymphangioleiomyomatosis Five Years after Bilateral-Lung Transplantation.
Heshmatnia J; Mirenayat MS; Rezaei M; Bongomin F; Bakhshayeshkaram M; Tabarsi P; Sheikhy K; Mortezaee V
Arch Iran Med; 2021 Sep; 24(9):701-703. PubMed ID: 34816687
[TBL] [Abstract][Full Text] [Related]
18. Lung transplantation for lymphangioleiomyomatosis: the French experience.
Reynaud-Gaubert M; Mornex JF; Mal H; Treilhaud M; Dromer C; Quétant S; Leroy-Ladurie F; Guillemain R; Philit F; Dauriat G; Grenet D; Stern M
Transplantation; 2008 Aug; 86(4):515-20. PubMed ID: 18724219
[TBL] [Abstract][Full Text] [Related]
19. Sirolimus for lymphangioleiomyomatosis lesions.
Egan JJ; Remund KF; Corris P
N Engl J Med; 2008 May; 358(18):1963-4; author reply 1964. PubMed ID: 18450609
[No Abstract] [Full Text] [Related]
20. Canadian respirologists' experience with lymphangioleiomyomatosis.
Pollock-BarZiv SM; Cohen MM; Maclean H; Downey GP
Can Respir J; 2002; 9(6):413-6. PubMed ID: 12522487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
